Quartz·1 min read·medium
FDA approved Replimune's melanoma treatment after rejecting it twice
✦AI Summary
The FDA has granted approval to Replimune's engineered viral therapy for melanoma. This decision follows two previous rejections based on concerns regarding the design of the company's clinical trials.
The agency had twice rejected the engineered viral therapy over concerns about the design of Replimune's clinical trial
healthbusiness
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in